Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $506.3600 (0.17%) ($506.3600 - $506.6700) on Thu. Jun. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.45% (three month average) | RSI | 41 | Latest Price | $506.3600(0.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -1.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(36%) SPLV(36%) IVW(35%) | Factors Impacting REGN price | REGN will decline at least -0.725% in a week (0% probabilities). VIXM(-21%) TBT(-7%) UUP(-6%) VXX(-5%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.725% (StdDev 1.45%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $502.22(0.82%) | 10 Day Moving Average | $502.68(0.73%) | 20 Day Moving Average | $505.53(0.16%) | To recent high | -3.3% | To recent low | 13.4% | Market Cap | $53.689b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |